VSQTF: A Liquid Way to Diversify Into Early-Stage Venture at a Deep Discount to NAV
By Lisa Thompson
OTC:VSQTF
READ THE FULL VSQTF RESEARCH REPORT
SCTL: An underappreciated opportunity in CDMOs – Initiating Coverage
By Beth Senko, CFA
NASDAQ:SCTL
READ THE FULL SCTL RESEARCH REPORT
HTCR: Established software provider of CMS and Digital Transformation products entering a new expansion and growth phase.
By Thomas Kerr, CFA
NASDAQ:HTCR
Overview
CFRX: DSMB Recommends DISRUPT Study be Stopped for Futility…
Bautz: By David Bautz, PhD
NASDAQ:CFRX
READ THE FULL CFRX RESEARCH REPORT
APLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…
Bautz: By David Bautz, PhD
OTC:APLIF | TSX:APLI.TO
READ THE FULL APLIF RESEARCH REPORT
EPIX: Encouraging Signs of Activity in Phase 1 Trial of EPI-7386…
By David Bautz, PhD
NASDAQ:EPIX
READ THE FULL EPIX RESEARCH REPORT
ATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT
PBSV: Lowering target; still a solid value
By Beth Senko, CFA
OTC:PBSV
READ THE FULL PBSV RESEARCH REPORT
NNBR: Diversified manufacturer focused on end markets with high growth rates such as electric vehicles and electric grid upgrade.
By Thomas Kerr, CFA
NASDAQ:NNBR
READ THE FULL NNBR RESEARCH REPORT